US-based contract research organisation WCCT Global has finished constructing a specialised clinical-research unit for vaccine trials in its home territory of Southern California.
The new facility includes 30 individual private rooms, separate heating, ventilation and air conditioning (HVCAC) systems, and dedicated units for virus and vaccine storage.
WCCT Global has also set up a streamlined process to recruit volunteers for vaccine clinical research using its proprietary recruitment tools.
The vaccine unit’s location in a densely populated region of Southern California is expected to provide a rich pool of potential volunteers.
WCCT already owns and operates five clinical research sites in California, including a Phase I unit in Cypress and a special populations unit in Costa Mesa.
In September, the company expanded its support services in ophthalmic medicine by acquiring OC Clinical Trials & Consulting in Santa Ana for an undisclosed sum.
The deal included research capabilities at two sites in Tustin, California.
“WCCT Global is aiming to be the leading full-service CRO in vaccine clinical research,” commented Lee Barsky, the company’s vice president of global clinical development.
“We have chosen to construct this new research unit to give our clients the premium level of service they deserve when it comes to vaccine clinical research.”